Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C

Journal of Viral Hepatitis

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2sUNLva
via IFTTT